Corpus Intelligence IC Memo — BYRD REGIONAL HOSPITAL 2026-04-26 19:07 UTC
IC Memo — BYRD REGIONAL HOSPITAL
Investment Committee Memorandum | LA | 39 beds | Grade C | EBITDA uplift $4.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BYRD REGIONAL HOSPITAL

CCN 190164 | VERNON PARISH, LA | 39 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BYRD REGIONAL HOSPITAL is a 39-bed suburban community hospital in VERNON PARISH, LA with $61.1M in net patient revenue and a 2.5% operating margin. The hospital serves a payer mix of 35.7% Medicare, 3.9% Medicaid, and 60.4% commercial.

Thesis: Turnaround. Our ML models identify $4.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 2.5% to 9.9% (+736bps).

Net Revenue HCRIS$61.1M
Current EBITDA COMPUTED$1.6M
Operating Margin COMPUTED2.5%
Occupancy HCRIS29.1%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS15.7%
Distress Probability ML50.9%

2. Market Context & Competitive Position

212
LA Hospitals
-3.5%
State Median Margin
125
Comparable Hospitals

LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of 2.5% places it above the state median. Among 125 size-comparable peers (20-78 beds), the median margin is -4.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-78), prioritizing same-state peers. 125 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BYRD REGIONAL HOSPITAL (Target)LA39$61.1M2.5%
UNIVERSITY HOSPITAL & CLINICSLA52$158.9M-33.4%
SOUTHERN REGIONAL MEDICAL CORPLA64$97.3M-50.0%
NEW ORLEANS EAST HOSPITALLA60$77.6M-29.7%
OCHSNER BAYOU LLCLA25$76.5M-0.9%
OUR LADY OF THE ANGELS HOSPITALA36$76.2M-4.9%
CENTRAL LOUISIANA SURGICAL HOSLA24$69.1M7.7%
ABBEVILLE GENERAL HOSPITALLA44$68.5M3.4%
ST. CHARLES PARISH HOSPITALLA27$64.0M-5.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.3M+210bp18mo
Cost to Collect4.5%2.5%$1.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$743K+122bp9mo
Clean Claim Rate88.0%96.0%$39K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.3M
Cost to Collect
$1.2M
Denial Rate Reduction
$1.2M
A/R Days Reduction
$743K
Clean Claim Rate
$39K
Total EBITDA Uplift$4.5M
Current EBITDA$1.6M
+ RCM Uplift+$4.5M
Pro Forma EBITDA$6.0M
Current Margin2.5%
Pro Forma Margin9.9%
WC Released (1x)$2.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.4M$55.2M23.13x87.4%
Base (11x exit)10.0x11.0x$2.4M$61.5M25.77x91.5%
Bull Case9.0x11.0x$2.1M$77.1M35.90x104.7%
Bull (12x exit)9.0x12.0x$2.1M$84.7M39.46x108.6%
Bear Case11.0x10.0x$2.6M$31.9M12.17x64.8%
Bear (11x exit)11.0x11.0x$2.6M$36.0M13.71x68.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 29.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 50.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 125 hospitals with 20-78 beds
  • Same-state prioritization (n=126)
  • Comp margins: P25=-21.3% / P50=-4.1% / P75=4.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.